10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,163,250 | -26.1% | 28,200 | 0.0% | 0.01% | -25.0% |
| Q2 2023 | $1,574,688 | +100007.3% | 28,200 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $1,573 | +53.0% | 28,200 | 0.0% | 0.01% | +50.0% |
| Q4 2022 | $1,028 | -99.9% | 28,200 | +69.9% | 0.01% | +14.3% |
| Q2 2022 | $751,000 | +159.9% | 16,600 | +336.8% | 0.01% | +250.0% |
| Q1 2022 | $289,000 | +120.6% | 3,800 | +322.2% | 0.00% | +100.0% |
| Q3 2021 | $131,000 | -97.1% | 900 | -96.1% | 0.00% | -96.4% |
| Q2 2021 | $4,550,000 | +442.3% | 23,238 | +401.0% | 0.03% | +460.0% |
| Q1 2021 | $839,000 | +27.7% | 4,638 | 0.0% | 0.01% | +25.0% |
| Q4 2020 | $657,000 | +166.0% | 4,638 | +133.9% | 0.00% | +100.0% |
| Q3 2020 | $247,000 | – | 1,983 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |